These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Squamous Cell Carcinoma AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Treatment
1391 results:

  • 1. Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-cell Lung Cancer-A Single-Center Experience.
    Kuang S; Chen K; Sayal S; Prabahan G; Rabey MR; Le LW; Seto A; Shepherd FA; Liu G; Bradbury P; Sacher AG; Law JH; Sabatini P; Stockley TL; Tsao MS; Leighl NB
    Curr Oncol; 2024 Aug; 31(8):4476-4485. PubMed ID: 39195317
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical and pathological characteristics of ovary mature cystic teratoma squamous cell carcinoma and primary ovarian squamous cell carcinoma].
    Zhan R; Yao YX; Gong CC; Zhang YS; Deng LF
    Zhonghua Yi Xue Za Zhi; 2024 Sep; 104(34):3252-3255. PubMed ID: 39193612
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma.
    Tsujikawa T; Ohno K; Morita KI; Saburi S; Mitsuda J; Yoshimura K; Kimura A; Morimoto H; Ogi H; Shibata S; Akashi T; Kurata M; Imoto I; Shimizu Y; Kano S; Watanabe A; Yamazaki T; Asada Y; Hayashi R; Saito Y; Ozawa H; Tsukahara K; Oridate N; Sano D; Horii A; Ueki Y; Maruo T; Mukoyama N; Hanai N; Fukusumi T; Iwai H; Fujisawa T; Fujii T; Nibu KI; Iwae S; Ueda T; Chikuie N; Yasumatsu R; Matsuo M; Umeno H; Ono T; Masuda M; Toh S; Itoh K; Hirano S; Asakage T
    Front Immunol; 2024; 15():1390873. PubMed ID: 39136017
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. p16, p53 and EGFR expression in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters.
    Gupta S; Pandey P; Verma S; Verma A
    J Cancer Res Ther; 2024 Apr; 20(3):881-887. PubMed ID: 39023595
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multiregion exome sequencing indicates a monoclonal origin of esophageal spindle-cell squamous cell carcinoma.
    Wang Y; Zhu Q; Wu Y; Li B; Su X; Xiang C; Han Y
    J Pathol; 2024 Sep; 264(1):55-67. PubMed ID: 39022845
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. TUSC3, p53 and p21 genetic association with development of oral submucous fibrosis and oral squamous cell carcinoma among addictive tobacco chewers of Pakistan.
    Zaidi SAA; Chughtai N; Abbassi ZA; Alam J; Malick TS; Salim A; Saleem S
    BMC Oral Health; 2024 Jul; 24(1):780. PubMed ID: 38992585
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel CAF-cancer cell crosstalk-related gene prognostic index based on machine learning: prognostic significance and prediction of therapeutic response in head and neck squamous cell carcinoma.
    Xu Y; Li J; Wang J; Deng F
    J Transl Med; 2024 Jul; 22(1):645. PubMed ID: 38982511
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma.
    Abdulrahman Z; Kortekaas KE; Welters MJP; van Poelgeest MIE; van der Burg SH
    Cancer Immunol Immunother; 2024 Jul; 73(9):166. PubMed ID: 38954042
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Fucoxanthin Induces Ferroptosis in Cancer cells via Downregulation of the Nrf2/HO-1/GPX4 Pathway.
    Du HF; Wu JW; Zhu YS; Hua ZH; Jin SZ; Ji JC; Wang CS; Qian GY; Jin XD; Ding HM
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930897
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunoreactivity of LMO7 and other molecular markers as potential prognostic factors in oropharyngeal squamous cell carcinoma.
    Israelsson P; Oda H; Öfverman C; Stefansson K; Lindquist D
    BMC Oral Health; 2024 Jun; 24(1):729. PubMed ID: 38918827
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Piperine-coated zinc oxide nanoparticles target biofilms and induce oral cancer apoptosis via BCl-2/BAX/p53 pathway.
    Shaik MR; Kandaswamy K; Guru A; Khan H; Giri J; Mallik S; Shah MA; Arockiaraj J
    BMC Oral Health; 2024 Jun; 24(1):715. PubMed ID: 38907185
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management.
    Tran NH; Sais D; Tran N
    J Med Virol; 2024 Jun; 96(6):e29746. PubMed ID: 38884391
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Experimental Verification of Erchen Decoction Plus Huiyanzhuyu Decoction in the treatment of Laryngeal squamous cell carcinoma Based on Network Pharmacology.
    Tan X; Luo Q; Hua Y; Zhou S; Peng G; Zhu R; Chen W; Li Y
    Integr Cancer Ther; 2024; 23():15347354241259182. PubMed ID: 38845538
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Elucidating the Role of Let-7d-5p and OLR1 in the Progression and Prognosis of Oral squamous cell carcinoma
    Lin CH; Chiang CC; Shih YC; Tung SL; Huang WC
    Anticancer Res; 2024 Jun; 44(6):2517-2531. PubMed ID: 38821588
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
    Fürstenau M; Kater AP; Robrecht S; von Tresckow J; Zhang C; Gregor M; Thornton P; Staber PB; Tadmor T; Lindström V; Juliusson G; Janssens A; Levin MD; da Cunha-Bang C; Schneider C; Goldschmidt N; Vandenberghe E; Rossi D; Benz R; Nösslinger T; Heintel D; Poulsen CB; Christiansen I; Frederiksen H; Enggaard L; Posthuma EFM; Issa DE; Visser HPJ; Bellido M; Kutsch N; Dürig J; Stehle A; Vöhringer M; Böttcher S; Schulte C; Simon F; Fink AM; Fischer K; Holmes EE; Kreuzer KA; Ritgen M; Brüggemann M; Tausch E; Stilgenbauer S; Hallek M; Niemann CU; Eichhorst B
    Lancet Oncol; 2024 Jun; 25(6):744-759. PubMed ID: 38821083
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Fisetin induces G2/M phase arrest and caspase-mediated cleavage of p21
    Yadav M; Kandhari K; Mathan SV; Ali M; Singh RP
    Mol Carcinog; 2024 Sep; 63(9):1697-1711. PubMed ID: 38801393
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer.
    Zhao J; Wang L; Zhou A; Wen S; Fang W; Zhang L; Duan J; Bai H; Zhong J; Wan R; Sun B; Zhuang W; Lin Y; He D; Cui L; Wang Z; Wang J
    Med; 2024 Aug; 5(8):981-997.e4. PubMed ID: 38781965
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.
    Mao L; Deng G; Li M; Lu SH; Jiang W; Yu X
    Eur J Med Res; 2024 May; 29(1):293. PubMed ID: 38773551
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
    Ma H; Wu T; Zhang Q; Ding Q
    BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer.
    Rustgi N; Wu S; Samec T; Walker P; Xiu J; Lou E; Goel S; Saeed A; Moy RH
    Cancer Res Commun; 2024 Jun; 4(6):1399-1409. PubMed ID: 38717153
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 70.